INVEGA (Paliperidone)

INVEGA (Paliperidone) is an atypical antipsychotic medication primarily used for the treatment of schizophrenia and schizoaffective disorder. It works by influencing the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which play key roles in mood and behavior regulation.

Some important highlights of INVEGA include:

• Indications: INVEGA is prescribed for adults and adolescents aged 12 years and older for the treatment of schizophrenia. It is also indicated for schizoaffective disorder, helping to stabilize mood and reduce psychotic symptoms.


• Dosing and Administration: The medication is available in extended-release tablets and can be taken once daily, with or without food. Dosages are tailored to individual needs, starting at a low dose and adjusted based on therapeutic response.


• Side Effects: Common side effects may include drowsiness, dizziness, weight gain, and increased blood sugar levels. Patients should be monitored for metabolic changes and other potential complications.


• Precautions: It is essential for patients to inform their healthcare provider of any pre-existing medical conditions, especially heart issues or diabetes, before starting INVEGA. Regular follow-ups are crucial to ensure the medication's efficacy and safety.


• Interactions: INVEGA can interact with other medications, so patients should disclose all current medications to their healthcare provider to avoid adverse effects.


• Long-Term Use: Some studies suggest that long-term use of INVEGA may help reduce the risk of relapse in patients with schizophrenia and maintain overall mental health stability.

In conclusion, INVEGA (Paliperidone) offers an effective treatment option for individuals struggling with certain mental health disorders. It is vital for patients to work closely with their healthcare providers to find the appropriate dosage and monitor any side effects throughout their treatment journey.

• Paliperidone


• Microcrystalline cellulose


• Croscarmellose sodium


• Lactose monohydrate


• Magnesium stearate


• Hypromellose


• Titanium dioxide


• Iron oxide red


• Iron oxide yellow

INVEGA (Paliperidone) is an antipsychotic medication primarily used to treat schizophrenia and schizoaffective disorder. It is essential to follow your healthcare provider's instructions carefully when using this medication.

Before starting INVEGA, inform your doctor about any allergies, pre-existing medical conditions, or if you are taking other medications, including over-the-counter drugs and supplements. This helps in preventing potential drug interactions and side effects.

INVEGA is usually taken once daily, with or without food. Consistency in timing is important for optimal effectiveness. Swallow the tablet whole with a glass of water; do not crush, chew, or split it.

If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.

Regular follow-up appointments with your healthcare provider are crucial to monitor your progress and adjust the dosage if necessary. Report any unusual symptoms or side effects, such as mood changes, sleep disturbances, or physical health concerns, promptly.

Do not stop taking INVEGA suddenly without consulting your doctor, as this may lead to withdrawal symptoms or a recurrence of your condition. If you need to discontinue the medication, your healthcare provider will guide you on how to taper off safely.

In case of an overdose, seek immediate medical attention. Symptoms of overdose may include severe drowsiness, confusion, or unusual movements.

While using INVEGA, avoid alcohol and be cautious with activities that require alertness, such as driving or operating heavy machinery, as the medication may cause drowsiness or dizziness.

For comprehensive information about INVEGA, including potential side effects and interactions, refer to the medication guide provided by your pharmacist or consult your healthcare provider. Always prioritize open communication with your healthcare team regarding your treatment plan.